Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 6:52 pm Purchase | 2025-08-14 | 13G | Plus Therapeutics, Inc. PSTV | S.H.N. Financial Investments Ltd. | 1,500,000 1.510% | 290,246 (+23.99%) | Filing History |
| 2025-07-29 4:05 pm Purchase | 2025-06-30 | 13G | Plus Therapeutics, Inc. PSTV | Orin Hirschman | 1,283,681 3.900% | 722,776 (+128.86%) | Filing History |
| 2025-06-25 4:22 pm Sale | 2025-06-24 | 13G | Plus Therapeutics, Inc. PSTV | The Hewlett Fund LP | 0 0.000% | -2,006,552 (Position Closed) | Filing History |
| 2025-05-22 3:20 pm Purchase | 2025-05-19 | 13G | Plus Therapeutics, Inc. PSTV | The Hewlett Fund LP | 2,006,552 8.255% | 2,006,552 (New Position) | Filing History |
| 2025-03-18 4:17 pm Purchase | 2025-03-04 | 13G | Plus Therapeutics, Inc. PSTV | S.H.N. Financial Investments Ltd. | 1,209,754 9.990% | 1,209,754 (New Position) | Filing History |
| 2025-02-10 08:27 am Sale | 2024-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Orin Hirschman | 560,905 9.500% | -7,776 (-1.37%) | Filing History |
| 2024-06-05 07:26 am Purchase | 2024-05-09 | 13G | Plus Therapeutics, Inc. PSTV | Orin Hirschman | 568,681 9.900% | 568,681 (New Position) | Filing History |
| 2023-02-13 3:25 pm Sale | 2022-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Parkman Healthcare Partners LLC | 38,898 1.700% | -61,669 (-61.32%) | Filing History |
| 2022-02-11 07:53 am Unchanged | 2021-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Mitchell P. Kopin | 20,000 1.900% | 0 (Unchanged) | Filing History |
| 2022-02-04 5:00 pm Purchase | 2022-01-28 | 13G | Plus Therapeutics, Inc. PSTV | Parkman Healthcare Partners LLC | 100,567 7.400% | 100,567 (New Position) | Filing History |
| 2022-02-04 4:10 pm Purchase | 2021-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Hudson Bay Capital Management LP | 36,667 3.460% | 1,302 (+3.68%) | Filing History |
| 2021-02-26 12:40 pm Unchanged | 2020-12-31 | 13G | Plus Therapeutics, Inc. PSTV | NanoTx Corp. | 15,385 4.830% | 0 (Unchanged) | Filing History |
| 2021-02-26 10:10 am Unchanged | 2020-12-31 | 13G | Plus Therapeutics, Inc. PSTV | NanoTx Corp. | 15,385 4.830% | 0 (Unchanged) | Filing History |
| 2021-02-10 3:22 pm Purchase | 2020-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Hudson Bay Capital Management LP | 35,365 9.990% | 7,466 (+26.76%) | Filing History |
| 2021-01-29 06:54 am Sale | 2020-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Mitchell P. Kopin | 20,000 5.900% | -7,039 (-26.03%) | Filing History |